18 results on '"Ding, Pei-Rong"'
Search Results
2. A nomogram for predicting cancer specific survival (CSS) in patients with pathological T3N0M0 (pT3N0M0) rectal cancer.
3. SONCAR study: A prospective randomized controlled study on optimized neoadjuvant chemotherapy-oxaliplatin plus CRT in patients with locally advanced rectal cancer.
4. Circulating tumor DNA as a promising biomarker of relapse risk for stage II-III colorectal cancer.
5. The prevalence of germline mutations in Chinese colorectal cancer patients with mismatch repair deficiency.
6. Effect of increasing radiation dose for rectal cancer patients with nonoperative management after neoadjuvant chemoradiotherapy.
7. Universal genetic screening for Chinese colorectal cancer patients with higher hereditary susceptibility.
8. Safety of intraoperative chemotherapy with 5-FU for colorectal cancer patients receiving curative resection: A randomized, multicenter, prospective, phase III IOCCRC trial (IOCCRC).
9. The correlation between mismatch repair status and clinicopathological characteristics in Chinese colorectal cancer patients.
10. The safety of four cycles of CAPEOX combined with radiotherapy vs. capecitabine combine with radiotherapy for locally advanced rectal cancer: Mid-term analysis of NCT02031939.
11. A pilot study of neoadjuvant chemoradiotherapy for unresectable locally advanced adherent colon cancer: Assessing local tumor response.
12. Safety and effectiveness of subtotal pelvic peritonectomy for patients with colorectal cancer with limited peritoneal metastasis in pelvic cavity.
13. Efficacy of PD-1 inhibitors for colorectal cancer and polyps in patients with Lynch syndrome.
14. Adjuvant systemic chemotherapy with or without hepatic arterial infusion of floxuridine in patients following colorectal cancer liver metastases resection (HARVEST): A prospective, randomized controlled trial.
15. Multi-center, randomized, controlled, open-label effectiveness study of primary tumor resection or not in asymptomatic colorectal cancer with unresectable metastatic disease.
16. Preoperative radiotherapy combined with simultaneous chemotherapy with capecitabine plus oxaliplatin versus surgery alone: A single-centered, phase II study in patients with mid/low rectal cancer.
17. Oxaliplatin and capecitabine initially concomitant to radiotherapy then administered in the resting period in high-risk locally advanced rectal cancer.
18. Induction chemotherapy followed by chemoradiotherapy and TME for high-risk locally advanced rectal cancer with and without synchronous resectable metastases.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.